Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-18
DOI
10.1186/s13045-022-01247-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of neoantigens for individualized therapeutic cancer vaccines
- (2022) Franziska Lang et al. NATURE REVIEWS DRUG DISCOVERY
- Granulocyte macrophage colony-stimulating factor has come of age: from a vaccine adjuvant to antiviral immunotherapy
- (2021) Maria Petrina et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Correction to: circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway
- (2021) Yinjie Su et al. Molecular Cancer
- Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
- (2021) Zhuting Hu et al. NATURE MEDICINE
- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- Recombinant protein vaccines, a proven approach against coronavirus pandemics
- (2021) Jeroen Pollet et al. ADVANCED DRUG DELIVERY REVIEWS
- A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
- (2021) Timothy J. Vreeland et al. ANNALS OF SURGICAL ONCOLOGY
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
- (2021) Valeria Morante et al. Viruses-Basel
- Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer—Results from Phase Ib Trial IMU.ACS.001
- (2021) Ursula Wiedermann et al. CLINICAL CANCER RESEARCH
- mRNA therapeutics in cancer immunotherapy
- (2021) Jan D. Beck et al. Molecular Cancer
- Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
- (2021) Alexander Spira et al. Targeted Oncology
- Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c melanoma
- (2021) Josep Malvehy et al. Journal for ImmunoTherapy of Cancer
- CpG-Based Nanovaccines for Cancer Immunotherapy
- (2021) Wenqiang Chen et al. International Journal of Nanomedicine
- Personalized DNA neoantigen vaccine in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma.
- (2021) Mark Yarchoan et al. JOURNAL OF CLINICAL ONCOLOGY
- Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors.
- (2021) Maura L. Gillison et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
- (2021) Otavio T Ranzani et al. BMJ-British Medical Journal
- DC-Derived Exosomes for Cancer Immunotherapy
- (2021) Yi Yao et al. Cancers
- A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
- (2020) Srinivas Ramishetti et al. ADVANCED MATERIALS
- The challenge and prospect of mRNA therapeutics landscape
- (2020) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
- (2020) Wenjun Wang et al. Nature Nanotechnology
- An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
- (2020) Katharina Reinhard et al. SCIENCE
- U1 snRNP regulates cancer cell migration and invasion in vitro
- (2020) Jung-Min Oh et al. Nature Communications
- Computational Prediction and Validation of Tumor-Associated Neoantigens
- (2020) Vladimir Roudko et al. Frontiers in Immunology
- TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
- (2020) Brenda De Keersmaecker et al. Journal for ImmunoTherapy of Cancer
- Tumor-Associated Macrophages: Recent Insights and Therapies
- (2020) Jiawei Zhou et al. Frontiers in Oncology
- Squaramides and Ureas: A Flexible Approach to Polymerase‐Compatible Nucleic Acid Assembly
- (2020) Arun Shivalingam et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- HPV vaccination and cancer prevention
- (2020) A. Athanasiou et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- Phase I trial of personalized mRNA vaccine encoding neoantigen in patients with advanced digestive system neoplasms.
- (2020) Xianbao Zhan et al. JOURNAL OF CLINICAL ONCOLOGY
- Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
- (2020) Lihong Wang-Bishop et al. Journal for ImmunoTherapy of Cancer
- A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
- (2020) Yanina Jansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Recent advances in mRNA vaccine technology
- (2020) Norbert Pardi et al. CURRENT OPINION IN IMMUNOLOGY
- cGAS-STING, an important pathway in cancer immunotherapy
- (2020) Minlin Jiang et al. Journal of Hematology & Oncology
- Oncolytic viruses for cancer immunotherapy
- (2020) Otto Hemminki et al. Journal of Hematology & Oncology
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
- (2020) Jesús Zepeda-Cervantes et al. Frontiers in Immunology
- Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer
- (2020) Erika J. Crosby et al. CLINICAL CANCER RESEARCH
- Recent developments of RNA-based vaccines in cancer immunotherapy
- (2020) Elnaz Faghfuri et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Self-amplifying RNA vaccines for infectious diseases
- (2020) Kristie Bloom et al. GENE THERAPY
- mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
- (2020) Gal Cafri et al. JOURNAL OF CLINICAL INVESTIGATION
- Dendritic cell biology and its role in tumor immunotherapy
- (2020) Yingying Wang et al. Journal of Hematology & Oncology
- Strategies in DNA vaccine for melanoma cancer
- (2020) Tayebeh Rezaei et al. Pigment Cell & Melanoma Research
- Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine
- (2020) Keven Lothert et al. Scientific Reports
- Dual-Antigen-Loaded Hepatitis B Virus Core Antigen Virus-like Particles Stimulate Efficient Immunotherapy Against Melanoma
- (2020) Keman Cheng et al. ACS Applied Materials & Interfaces
- Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
- (2020) Jin Won Youn et al. LANCET ONCOLOGY
- Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
- (2020) Stephen A Boorjian et al. LANCET ONCOLOGY
- Myeloid and plasmacytoid dendritic cell combined vaccines loaded with heat‑treated tumor cell lysates enhance antitumor activity in murine lung cancer
- (2020) Huiguo Chen et al. Oncology Letters
- DC-Based Vaccines for Cancer Immunotherapy
- (2020) Chunmei Fu et al. Vaccines
- Vaccine-induced memory CD8+ T cells provide clinical benefit in HER2 expressing breast cancer: a mouse to human translational study
- (2019) Erika J Crosby et al. CLINICAL CANCER RESEARCH
- FTSJ3 is an RNA 2′-O-methyltransferase recruited by HIV to avoid innate immune sensing
- (2019) Mathieu Ringeard et al. NATURE
- Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
- (2019) Zong Sheng Guo et al. Journal for ImmunoTherapy of Cancer
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
- (2019) Alexandros Papachristofilou et al. Journal for ImmunoTherapy of Cancer
- A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
- (2019) Elizabeth K. Duperret et al. Cancer Immunology Research
- Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site
- (2019) Anna Lysén et al. Scientific Reports
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial
- (2019) Elizabeth A. Mittendorf et al. CLINICAL CANCER RESEARCH
- Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Hyun Cheol Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
- (2019) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
- (2019) Kalijn F. Bol et al. Journal for ImmunoTherapy of Cancer
- Studying interactions between dendritic cells and T cells in vivo
- (2019) Aleksey Chudnovskiy et al. CURRENT OPINION IN IMMUNOLOGY
- Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
- (2019) Reem Saleh et al. SEMINARS IN CANCER BIOLOGY
- Trial watch: dendritic cell vaccination for cancer immunotherapy
- (2019) Jenny Sprooten et al. OncoImmunology
- The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
- (2019) Luca Mazzarella et al. EUROPEAN JOURNAL OF CANCER
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- A trans-amplifying RNA vaccine strategy for induction of potent protective immunity
- (2019) Tim Beissert et al. MOLECULAR THERAPY
- Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges
- (2019) Goto Vaccines
- A phase 2, prospective, randomized, multicenter, open-label study of GX-188E, an HPV DNA vaccine, in patients with cervical intraepithelial neoplasia 3
- (2019) Youn Jin Choi et al. CLINICAL CANCER RESEARCH
- Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
- (2019) Li Yang et al. Journal of Hematology & Oncology
- Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
- (2019) Sergio Linares-Fernández et al. TRENDS IN MOLECULAR MEDICINE
- Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies
- (2019) Jia Yang et al. PATHOLOGY RESEARCH AND PRACTICE
- Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
- (2019) Victoria D. Turubanova et al. Journal for ImmunoTherapy of Cancer
- Antitumor Humoral and T Cell Responses by Mucin-1 Conjugates of Bacteriophage Qβ in Wild-type Mice
- (2018) Zhaojun Yin et al. ACS Chemical Biology
- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
- (2018) Xuhao Ni et al. Cancer Discovery
- PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease
- (2018) Priya Srinivasan et al. PLOS MEDICINE
- Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
- (2018) Sriram Vaidyanathan et al. Molecular Therapy-Nucleic Acids
- M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
- (2018) Karin M. Knudson et al. OncoImmunology
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Acetylation of Cytidine in mRNA Promotes Translation Efficiency
- (2018) Daniel Arango et al. CELL
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes
- (2018) Daniel B. Graham et al. NATURE MEDICINE
- MDSC; the Most Important Cell You Have Never Heard Of
- (2018) R.J. Tesi TRENDS IN PHARMACOLOGICAL SCIENCES
- Reduced Breast Tumor Growth after Immunization with a Tumor-Restricted MUC1 Glycopeptide Conjugated to Tetanus Toxoid
- (2018) Natascha Stergiou et al. Cancer Immunology Research
- Oncolytic virus immunotherapy: future prospects for oncology
- (2018) Junaid Raja et al. Journal for ImmunoTherapy of Cancer
- Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results
- (2018) Jacek Mackiewicz et al. Journal for ImmunoTherapy of Cancer
- Emerging experience with meningococcal serogroup B protein vaccines
- (2017) Daniela Toneatto et al. Expert Review of Vaccines
- Danger signals: Chemotherapy enhancers?
- (2017) Thaiz Rivera Vargas et al. IMMUNOLOGICAL REVIEWS
- Myeloid-derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
- (2017) Jason A. Chesney et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
- (2017) Yuchen Fan et al. NANO LETTERS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- The problem with neoantigen prediction
- (2017) NATURE BIOTECHNOLOGY
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Short poly(A) tails are a conserved feature of highly expressed genes
- (2017) Sarah Azoubel Lima et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
- (2017) Stephan Halle et al. TRENDS IN IMMUNOLOGY
- Short poly(A) tails are a conserved feature of highly expressed genes
- (2017) Sarah Azoubel Lima et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
- (2017) John J. Suschak et al. Human Vaccines & Immunotherapeutics
- Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma
- (2017) Alessandra Lopes et al. Molecular Therapy-Nucleic Acids
- Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model
- (2017) Cameron S. Field et al. OncoImmunology
- Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC
- (2017) Caroline Tosch et al. Journal for ImmunoTherapy of Cancer
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
- (2016) Robert A. Fenstermaker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy against cancer-related viruses
- (2016) Haruko Tashiro et al. CELL RESEARCH
- Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
- (2016) K. F. Bol et al. CLINICAL CANCER RESEARCH
- DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
- (2016) Angeliki Tiptiri-Kourpeti et al. PHARMACOLOGY & THERAPEUTICS
- Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF
- (2016) Tsuguhide Takeshima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Forced co-expression of IL-21 and IL-7 in whole-cell cancer vaccines promotes antitumor immunity
- (2016) Yang-Zhuo Gu et al. Scientific Reports
- Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model
- (2016) Tomoki Yamano et al. Molecular Therapy-Oncolytics
- Adjuvants for peptide-based cancer vaccines
- (2016) Hiep Khong et al. Journal for ImmunoTherapy of Cancer
- Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study
- (2015) Katy J. McCann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
- (2015) Kevin J. Kauffman et al. NANO LETTERS
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Mutation-Specific T Cells for Immunotherapy of Gliomas
- (2015) Cornelis J.M. Melief NEW ENGLAND JOURNAL OF MEDICINE
- An Ebola whole-virus vaccine is protective in nonhuman primates
- (2015) A. Marzi et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Neoepitopes of Cancers: Looking Back, Looking Ahead
- (2015) P. K. Srivastava Cancer Immunology Research
- Immunogenicity of necrotic cell death
- (2014) Jaba Gamrekelashvili et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients
- (2014) S. Occhipinti et al. CLINICAL CANCER RESEARCH
- Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer
- (2014) V. Tiriveedhi et al. CLINICAL CANCER RESEARCH
- Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
- (2014) Y. Yoshitake et al. CLINICAL CANCER RESEARCH
- Adenovirus-Based Vaccines for Fighting Infectious Diseases and Cancer: Progress in the Field
- (2014) Dragomira Majhen et al. HUMAN GENE THERAPY
- Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
- (2014) S. Adams et al. JOURNAL OF IMMUNOLOGY
- A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients
- (2014) J Bae et al. LEUKEMIA
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial
- (2014) O. Bloch et al. NEURO-ONCOLOGY
- In vitro and in vivo Repair Activities of Undifferentiated and Classically and Alternatively Activated Macrophages
- (2014) Zoé Enderlin Vaz da Silva et al. PATHOBIOLOGY
- Increased Generation of HIV-1 gp120-Reactive CD8+ T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3
- (2014) Inger Øynebråten et al. PLoS One
- Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
- (2014) Marius M. Strioga et al. VACCINE
- From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
- (2014) Paola Italiani et al. Frontiers in Immunology
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- TGF-β Activation and Function in Immunity
- (2013) Mark A. Travis et al. Annual Review of Immunology
- Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α
- (2013) Ji Cao et al. BIOCHEMICAL PHARMACOLOGY
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Macrophages: Supportive cells for tissue repair and regeneration
- (2013) Bénédicte Chazaud IMMUNOBIOLOGY
- Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
- (2013) Hiroyuki Suzuki et al. Journal of Translational Medicine
- Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responses
- (2013) Juhong Jiang et al. Journal of Translational Medicine
- Oral Vaccination With Adeno-associated Virus Vectors Expressing the Neu Oncogene Inhibits the Growth of Murine Breast Cancer
- (2013) Jason C Steel et al. MOLECULAR THERAPY
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- The intimate relationships of mRNA decay and translation
- (2013) Bijoyita Roy et al. TRENDS IN GENETICS
- Challenges and advances towards the rational design of mRNA vaccines
- (2013) Charlotte Pollard et al. TRENDS IN MOLECULAR MEDICINE
- DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer
- (2013) Fredrik Eriksson et al. VACCINE
- Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
- (2013) Ryuji Okuyama et al. OncoImmunology
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Technologies for enhanced efficacy of DNA vaccines
- (2012) Fadi Saade et al. Expert Review of Vaccines
- Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
- (2012) B. Zakeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T-Cell Tolerance: Central and Peripheral
- (2012) Y. Xing et al. Cold Spring Harbor Perspectives in Biology
- Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
- (2012) Thomas Gardner et al. Human Vaccines & Immunotherapeutics
- Overcoming HLA restriction in clinical trials
- (2012) An M.T. Van Nuffel et al. OncoImmunology
- Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung Metastases
- (2011) Thorsten Klamp et al. CANCER RESEARCH
- PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
- (2011) Paola Milla et al. CURRENT DRUG METABOLISM
- Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
- (2011) Cheryl Lai-Lai Chiang et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- A diverse range of gene products are effectors of the type I interferon antiviral response
- (2011) John W. Schoggins et al. NATURE
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Cellular Vaccine Approaches
- (2010) Dung T. Le et al. CANCER JOURNAL
- RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection
- (2010) Jan Rehwinkel et al. CELL
- Translating Tumor Antigens into Cancer Vaccines
- (2010) Luigi Buonaguro et al. Clinical and Vaccine Immunology
- DNA vaccines: an historical perspective and view to the future
- (2010) Margaret A. Liu IMMUNOLOGICAL REVIEWS
- DNA Vaccines: Developing New Strategies against Cancer
- (2010) Daniela Fioretti et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Whole tumor antigen vaccines
- (2010) Cheryl Lai-Lai Chiang et al. SEMINARS IN IMMUNOLOGY
- Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection
- (2010) Florence Faurez et al. VACCINE
- TLR-based immune adjuvants
- (2010) Folkert Steinhagen et al. VACCINE
- Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects
- (2009) H.-I. Cho et al. CANCER RESEARCH
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
- (2008) Martijn S. Bijker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started